Publication

Metathesiophobia: from Preclinical to Clinical Development

The future of science communication appears to be becoming progressively less dependent on traditional journals and more reliant on direct,...

From Index Medicus to PubMed in seconds. A personal reflection on how scientific literature searching has changed and what the old ways...

Should you post your research as a preprint? A balanced look at the visibility benefits, peer review concerns and reputational risks authors...

Publishing is just the first step. Ten practical activities to increase the discoverability and impact of your research in a crowded...

Self-doubt is common among medical writers. Practical techniques for evaluating your own writing objectively and developing your craft with...

Most writers fear judgement of their work. Practical techniques for reviewing your own writing objectively and building confidence as a...

Discover ten evidence-based strategies to promote scientific research, improve dissemination, increase impact, and strengthen long-term...

Paper mills, AI fraud and a broken peer review system are threatening the scientific record. A look at the publishing integrity crisis and...

The landscape of diabetes care is shifting as the global population ages.

The sudden imposition of remote working in response to the 2020 COVID-19

Are you a werewolf, ghost, vampire or zombie at conferences? Explore the psychology of conference behaviour — and how to avoid becoming a...

There are many regulatory documents but perhaps none are more critical

A practical guide to responding to manuscript rejection with three steps and key tips for revising, rebutting reviewers, and resubmitting...

We all get them, some of us more than 10 a day, emails from journals

The proceedings of the Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI)

Never judge a book by its cover –we know

The EUropean Federation for Exploratory MEdicines Development (EUFEMED

The comparison of the DPP4 (dipeptidyl peptidase 4) SARS-CoV-2

Welcome to the seventh issue of the Refractory Asthma Stratification Programme (RASP-UK) newsletter

Early in 2020, COVID-19 was spreading rapidly across the globe.

Biologic therapies for severe asthma, monoclonal antibodies targeting key type‑2 inflammatory pathways.

As a jobbing scientist you rarely spend your whole career working on the same project.

If you have been involved in the pharmaceutical industry for any length

When a country’s economy becomes so dominated by a single export industry

Our publication on the potential benefits of bariatric surgery

Epidemiological data suggest that at two in five of us will experience

The scientific literature comprises scholarly publications that report original

Phase I is the lifeblood or new medicines. The UK’s Phase I representative body,

Asthma is a chronic inflammatory disorder of the airways

The UK's world-class human challenge study gives us new information about SARS-CoV-2 cases that were mild in 36 healthy young volunteers who...

There have been hundreds of thousands of deaths from COVID-19

Work never stops and after the findings of our ground breaking survey in the EMWA

Phenotype-specific omic expression patterns in people with frailty could provid

In this case the plan is a paradigm shift in the way we will manage

The latest issue of Journal Frontiers in Pharmacology has just published

I'm sure that everyone works hard and tries to do their best.

Our publication on effectiveness of a multimodal intervention

One notable characteristic of Brexit has been a race for the bottom by journalists

ive years ago I was lucky enough to be involved in a project that resulted in publications

Because new biologic treatments for asthma can be expensive and cause side effects,

Welcome everyone to the first issue of the Frailomic consortium

Publication planning provides the framework through which research findings are transformed into scientific knowledge and societal benefit.